Dashboard
OTHER dominates black-box stock, INDUSTRY leads on large-class black-box rate, the United States still carries the biggest national stock, and healthy volunteers are the sharpest condition-family extreme.
OTHER dominates black-box stock on count, INDUSTRY has the highest large-class black-box rate, the United States remains the largest country-linked stock, and healthy-volunteer portfolios are the sharpest condition-family extreme.
OTHER dominates black-box stock, INDUSTRY leads on large-class black-box rate, the United States still carries the biggest national stock, and healthy volunteers are the sharpest condition-family extreme.
Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.
Industry project from the CT.gov hiddenness series.
Sponsor-class project from the CT.gov hiddenness series.
Phase project from the CT.gov hiddenness series.
Structural missingness project from the CT.gov hiddenness series.
Evidence visibility project from the CT.gov hiddenness series.
Completion cohort project from the CT.gov hiddenness series.
Condition hiddenness project from the CT.gov hiddenness series.
Sponsor concentration project from the CT.gov hiddenness series.
Rule-era reporting project from the CT.gov hiddenness series.
Publication undercount audit from the CT.gov hiddenness series.
Oncology hiddenness project from the CT.gov hiddenness series.
Cardiovascular hiddenness project from the CT.gov hiddenness series.
Metabolic hiddenness project from the CT.gov hiddenness series.
Enrollment-size project from the CT.gov hiddenness series.
Geography-scale project from the CT.gov hiddenness series.
Design-purpose project from the CT.gov hiddenness series.
Completion-delay project from the CT.gov hiddenness series.
Trial-architecture project from the CT.gov hiddenness series.
Intervention-type project from the CT.gov hiddenness series.
Country reporting project from the CT.gov hiddenness series.
Stopped-trial project from the CT.gov hiddenness series.
Outcome-density project from the CT.gov hiddenness series.
Actual-field project from the CT.gov hiddenness series.
US-versus-global project from the CT.gov hiddenness series.
Modality-sponsor project from the CT.gov hiddenness series.
Country-condition project from the CT.gov hiddenness series.
Disease-geography project from the CT.gov hiddenness series.
Condition-sponsor project from the CT.gov hiddenness series.
Country-sponsor project from the CT.gov hiddenness series.
US-versus-ex-US project from the CT.gov hiddenness series.
Industry-family project from the CT.gov hiddenness series.
Risk-adjusted hiddenness from the CT.gov hiddenness series.
Overdue results clock from the CT.gov hiddenness series.
Publication index gap from the CT.gov hiddenness series.
Probable ACT/FDAAA debt from the CT.gov hiddenness series.
Sponsor-level adjusted watchlist showing which named sponsors still carry the largest excess hiddenness stock.
Country-linked adjusted watchlist showing which national portfolios remain worse than expected after visible study mix is held more constant.
Condition-family watchlist showing which therapeutic areas still carry excess no-results and ghost-protocol stock.
Strict U.S.-nexus repeater tables showing which sponsors and classes dominate the regulated-looking backlog.